Evidence map›Paper›PMID 31393073›Full record

Observational studyPediatric pulmonology2019

Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough.

Jennifer J Meerburg, Mehdi Albasri, Els C van der Wiel, Eleni-Rosalina Andrinopoulou, Menno M van der Eerden, Christof J Majoor, Hubertus G M Arets, Harry G M Heijerman, Harm A W M Tiddens

Abstract readObservational Study
In one paragraph

Observational study in Pediatric pulmonology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jennifer J MeerburgDepartment of Paediatric Pulmonology and Allergology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0001-7347-9065
Mehdi AlbasriDepartment of Paediatric Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Els C van der WielDepartment of Paediatric Pulmonology and Allergology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
Eleni-Rosalina AndrinopoulouDepartment of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.
Menno M van der EerdenDepartment of Pulmonology, Erasmus Medical Center, Rotterdam, The Netherlands.
Christof J MajoorDepartment of Pulmonology, Amsterdam University Medical Center, AMC, Amsterdam, The Netherlands.
Hubertus G M AretsDepartment of Pediatric Pulmonology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
Harry G M HeijermanDepartment of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.
Harm A W M TiddensDepartment of Paediatric Pulmonology and Allergology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa are on maintenance tobramycin inhalation therapy. Cough is reported as a side effect of tobramycin inhalation powder (TIP) in 48% of the patients. Objectives of this study were to investigate the association between the inspiratory flow of TIP and cough and to study the inhalation technique. We hypothesized that cough is related to a fast inhalation. MATERIALS AND

methodsIn this prospective observational study, CF patients ≥ 6 years old on TIP maintenance therapy from four Dutch CF centers were visited twice at home. Video recordings were obtained and peak inspiratory flow (PIF) was recorded while patients inhaled TIP. Between the two home visits, the patients made three additional videos. CF questionnaire-revised, spirometry data, and computed tomography scan were collected. Two observers scored the videos for PIF, cough, and mistakes in inhalation technique. The associations between PIF and cough were analyzed using a logistic mixed-effects model accounting for FEV

resultsTwenty patients were included, median age 22 (18-28) years. No significant associations were found between PIF and cough. The risk of cough was highest after inhalation of the first capsule when compared to the second, third, and fourth capsule (P ≤ .015). Fourteen patients (70%) coughed at least once during TIP inhalation. A breath-hold of less than 5 seconds after inhalation and no deep expiration before inhalation were the most commonly observed mistakes.

conclusionPIF is not related to cough in CF patients using TIP.

Indexed as

Administration, InhalationAdolescentAdultAnti-Bacterial AgentsChildCoughCystic FibrosisFemaleHumansMalePowdersProspective StudiesPseudomonas aeruginosaPseudomonas InfectionsRespiratory Function TestsTobramycinAnti-Bacterial AgentsPowdersTobramycincoughcystic fibrosisdry powder inhalerinhalationtobramycin

Identifiers

PMID31393073
PMCPMC6852538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.